MangoRx Review: $299 a Month for a Semaglutide Tablet You Dissolve

$299 a month, and unusually for this category that is the end of the arithmetic. There is no membership, no separate consultation charge and no shipping line — the banner across every page reads "Free provider visits and shipping on all orders", and MangoRx's own support FAQ says the monthly subscription "covers provider review and consultations, lab coordination (including lab orders where required), and your prescribed medication if approved". The figure was read off mangorx.com/products/slim on August 9, 2026 and confirmed against the catalogue the page itself queries, which returns pricebase 299 with pricesale 0. Twelve months at that rate is $3,588.

No. MangoRx sells Slim in three daily strengths — 2 mg, 4 mg and 6 mg — and its product catalogue returns pricebase 299 for all three, with the subscription SKU at the same number. That matters more than it sounds. Semaglutide is a titration drug: you start low and climb, and most sellers in this category re-price at each step, so a quoted starting-dose price understates what month six costs. MangoRx's does not, which means the $3,588 annual figure holds whether you settle at 2 mg or 6 mg.

It is expensive for what it is, and the comparison that matters is not other tablets but injections. Compounded injectable semaglutide from telehealth sellers generally lands between roughly $200 and $300 a month all-in, so MangoRx is at or above the top of that band for a product with far less behind it. The premium buys exactly one thing: no needle. If a weekly subcutaneous injection is the reason you have not started, that is a real problem worth paying to solve. If it is not, you are paying injectable money for a delivery route nobody has shown to be equivalent.

Nobody has published data saying it does, and the approved product's own label points the other way. Semaglutide is a peptide and is destroyed in the gut, which is why the only FDA-approved oral version pairs it with an absorption enhancer and carries a strict protocol: take it on an empty stomach with no more than four ounces of plain water, wait at least thirty minutes before eating or drinking, and — in the label's words — "Swallow tablets whole. Do not split, crush, chew or dissolve in any solution." A tablet designed to dissolve on the tongue is the exact opposite instruction. That is not proof it fails; it is an absence of any evidence that it works, at a price set as though it does. Ask MangoRx's provider what absorption they are dosing against before you buy.

MangoRx gives two different answers, and the difference is $80. Its support FAQ says: "The order will be canceled immediately and the amount captured at purchase will be refunded to the credit card." Its published refund policy says: "If you or your provider decide that GLP-1s are not a good fit for you post-appointment, you will only be charged for the tele-health consultation. For a video consult your card will be charged $80 and for a phone consult, the fee charged will be $70." Both were live on August 9, 2026. The refund policy is the document you agree to at checkout, so plan for the $80 and treat a full refund as the better outcome rather than the promised one. Cancelling the appointment inside 24 hours, or not showing up, is also an $80 charge.

No. MangoRx's position is flat: "like all prescription medications governed by state and federal law, returns are not accepted and all sales are final once fulfilled." That is standard for compounded prescriptions and is not a mark against MangoRx specifically, but it changes how the monthly billing should be read. Because the product is sold as a 30-day supply with a monthly subscription option rather than a multi-month block, the most you can be exposed to is one cycle you did not want — which is a genuine advantage over sellers whose cheap headline requires paying for three or six months at once.

Probably — it publishes the list rather than a count. As of August 9, 2026 MangoRx ships to 46 states plus Washington, D.C. The four absences are Alabama, Alaska, Arkansas and Mississippi. MangoRx explains the pattern as a function of "telehealth technology compliance with state law, treatment option allowability via telehealth, and physician licensing eligibility", and invites people in uncovered states to email for a notification list. Note this is the company-wide shipping list: MangoRx publishes no separate state table for Slim, and its FAQ hub has no weight-loss section in which one could appear.

No. The live FDA warning-letter index was queried on August 9, 2026 for "mangorx", "mango rx" and "mangoceuticals" — the corporate name is Mangoceuticals, Inc., trading as MangoRx — and each returned zero records. A broad search on "mango" returned 113 letters, every one of them read, and none names Mangoceuticals or MangoRx in the company column; they are vape, tobacco and produce letters that happen to mention a flavour. A control query for a company known to hold a 2026 telehealth letter returned it under the same query shape, so the zero here is a result rather than a broken instrument.

Nausea, according to MangoRx: "One of the most common barriers to GLP-1 therapy is gastrointestinal discomfort, particularly nausea. Slim includes Vitamin B6, which has been shown to help alleviate nausea." B6 is well established as an antiemetic in pregnancy, which is presumably the evidence being leaned on, and it is cheap. It also has a ceiling: sustained high-dose pyridoxine can cause peripheral neuropathy, so the dose is worth asking about rather than assuming. Practically, the B6 is not what you are paying $299 for — it is a few cents of an over-the-counter vitamin bundled into a compounded prescription, and it does not change the value question about the semaglutide it is bundled with.